Retiro De Equipo (Recall) de Device Recall Zimmer Biomet

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Zimmer Biomet, Inc..

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    77223
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-2198-2017
  • Fecha de inicio del evento
    2017-05-08
  • Fecha de publicación del evento
    2017-05-22
  • Estado del evento
    Terminated
  • País del evento
  • Fecha de finalización del evento
    2017-12-01
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    unknown device name - Product Code N/A
  • Causa
    Durability characteristics of reusable instruments were not established.
  • Acción
    On 5/8/2017, URGENT MEDICAL DEVICE RECALL (CORRECTION) notifications were sent to the affected US sales representatives and distributors via e-mail. The recall notification included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification. Your Responsibilities: 1. Review this notification and ensure affected team members are aware of the contents. 2. Distributors return the Attachment 1 Acknowledgment Form to corporatequality.postmarket@zimmerbiomet.com (Return one form per territory. Sales representatives do not need to sign an acknowledgment form.) 3. Training will automatically be assigned to sales representatives and distributors, and a list of these trainees will be provided. Review the list of trainees to ensure that all applicable sales representatives are listed. If you have additional trainees to report, send a list that includes the trainees name, title, and email address to corporatequality.postmarket@zimmerbiomet.com. 4. Access the computer-based training. a. Log into Biomet University and navigate to your learning requirements. b. Complete the computer-based training module for the Reusable Instrument Lifespan Manual listed in your learning requirements. c. Complete the accompanying course assessment. 5. Access the RILM one of two ways: a. Via direct link http://www.zimmer.com/medical-professionals/support/disassembly-manual-reusable-instrument-lifespan-manual.html b. Via path Zimmer.com¿Medical Professionals¿Support Drop-Down¿Disassembly Manual/Reusable Instrument Lifespan Manual. 6. Immediately begin using the RILM to evaluate reusable instruments according to the training guidance. 7. If you have questions about the RILM, please contact Michael Aziz: Michael.Aziz@zimmerbiomet.com. International distributors will be notified via email. Further distribution of international notices will be sent through the local and

Device

  • Modelo / Serial
    All lots in distribution prior to 5/8/17
  • Distribución
    Nationwide Worldwide
  • Descripción del producto
    Reusable instruments in the Knee, Hip, Trauma, and Extremities segments.
  • Manufacturer

Manufacturer

  • Dirección del fabricante
    Zimmer Biomet, Inc., 1800 W Center St, Warsaw IN 46580-2304
  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    USFDA